What is the growth forecast for the Artificial Transcatheter Heart Valve market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Artificial Transcatheter Heart Valve market?

Key drivers include rising cardiovascular disease prevalence and advancements in minimally invasive technologies.

What are the major challenges facing the Artificial Transcatheter Heart Valve market?

Challenges include high procedure costs and limited reimbursement in developing regions.

Which regions are leading the Artificial Transcatheter Heart Valve market?

North America and Europe are regional leaders, due to strong healthcare infrastructure.

Who are the top companies in the Artificial Transcatheter Heart Valve market?

Top companies include Medtronic, Edwards Lifesciences, and Boston Scientific, driving innovation.

What future opportunities exist in the Artificial Transcatheter Heart Valve market?

Future opportunities include emerging markets and advancements in valve design and materials.

How is technology impacting the Artificial Transcatheter Heart Valve market?

Advances in imaging and valve design are improving procedure outcomes and patient experience.

What is the current regulatory landscape for the Artificial Transcatheter Heart Valve market?

Regulatory bodies are implementing stricter guidelines for device approval and post-market surveillance.

What is the future outlook for the Artificial Transcatheter Heart Valve market?

The future outlook is positive, with increasing adoption and advancements in technology and materials.

Which Companies Lead the Artificial Transcatheter Heart Valve Market in 2026?

Artificial Transcatheter Heart Valve by Application (Aortic Stenosis, Aortic Regurgitation, Others), by Types (Aortic Heart Valve, Mitral Heart Valve, Tricuspid Heart Valve), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Artificial Transcatheter Heart Valve Market Size | CAGR 12.1 Forecast 2033

Which Companies Lead the Artificial Transcatheter Heart Valve Market in 2026?

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Artificial Transcatheter Heart Valve Market Overview

The Artificial Transcatheter Heart Valve market refers to the industry involved in the development and implementation of artificial heart valves that can be implanted through a transcatheter procedure, a minimally invasive technique. As the Artificial Transcatheter Heart Valve market size is expected to grow significantly, driven by its growth outlook and market forecast, the industry is poised for substantial industry expansion. The scope of this market encompasses various types of transcatheter heart valves, including transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR), catering to different applications and end-users, such as hospitals and cardiac centers. The current Artificial Transcatheter Heart Valve market size is approximately $6.1 billion, with a projected growth forecast and a compound annual growth rate (CAGR) of around 12-15% from 2026 to 2033. Key macro drivers include an aging population, an increase in heart valve diseases, and advancements in medical technology.

Loading chart…

The Artificial Transcatheter Heart Valve market is shaped by several key forces, including technology shifts towards more minimally invasive procedures, regulatory approvals that influence the adoption of new devices, and consumer behavior that demands better healthcare outcomes with less recovery time. The largest region in this market is currently North America, while the fastest-growing region is anticipated to be Asia-Pacific, driven by increasing healthcare expenditure and a growing awareness of heart valve diseases. As the industry continues to evolve, understanding these dynamics will be crucial for C-suite, strategic planners, and BD teams to make informed decisions and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	26.18 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Edwards Lifesciences; Medtronic; Abbott; Livanova; Boston Scientific; Cryolife; Suzhou Jiecheng Medical Technology Co.,Ltd.; Labcor Laboratórios Ltda; Braile Biomédica; MicroPort Scientific Corporation; Beijing Balance Medical Technology Co.,Ltd.; Myval
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Artificial Transcatheter Heart Valve market is poised for significant growth, driven by factors that are reshaping the industry landscape. Understanding these dynamics is crucial for strategy leaders and business development heads to navigate this complex market effectively.

Growth Drivers2 items

Advancements in minimally invasive technologies are expanding the treatable patient population, contributing to the growth of the Artificial Transcatheter Heart Valve market size. This trend is expected to continue, influencing the market's growth forecast.

Increasing prevalence of valvular heart disease and the growing demand for effective, less invasive treatments are driving innovation and adoption in the Artificial Transcatheter Heart Valve market.

Restraints2 items

High device costs and the requirement for specialized training for healthcare professionals are significant restraints on the widespread adoption of Artificial Transcatheter Heart Valve technologies, affecting the overall market size and growth forecast.

Stringent regulatory approvals and varying reimbursement policies across different regions pose challenges for manufacturers, potentially slowing the growth of the Artificial Transcatheter Heart Valve market.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, offer significant growth opportunities for Artificial Transcatheter Heart Valve manufacturers due to their large and underserved patient populations, contributing to the positive growth forecast of the market.

The development of next-generation Artificial Transcatheter Heart Valve systems with enhanced durability and performance presents opportunities for innovation and market differentiation, driving the Artificial Transcatheter Heart Valve market forward.

Challenges2 items

Managing the supply chain to ensure consistent and high-quality component delivery is a challenge for manufacturers, as it directly impacts the production and availability of Artificial Transcatheter Heart Valve systems, influencing the market's growth dynamics.

The need to demonstrate long-term efficacy and cost-effectiveness of Artificial Transcatheter Heart Valve treatments to payers and regulatory bodies is an ongoing challenge that affects market adoption and the overall growth forecast of the Artificial Transcatheter Heart Valve market.

Market Segmentation

Loading chart…

The Artificial Transcatheter Heart Valve segmentation by application includes various categories that contribute to the overall market size. This segmentation is crucial in understanding the market taxonomy and identifying areas of growth. The application segment can be further divided into subtypes, such as transcatheter aortic valve replacement and transcatheter mitral valve replacement. These subtypes have distinct characteristics and are used to treat different heart valve disorders.

The types of Artificial Transcatheter Heart Valves can be segmented into various subtypes, including mechanical valves and biological valves. These subtypes have different material compositions and are used in different patient populations. The mechanical valves are further divided into ball-and-cage valves, tilting-disk valves, and bileaflet valves. The biological valves are made from animal tissues and are divided into stented valves and stentless valves. Understanding these subtypes is essential for Artificial Transcatheter Heart Valve market analysis.

Artificial Transcatheter Heart Valve Segmentation Breakdown8 items

Application

Aortic Stenosis

Aortic Regurgitation

Others

Types

Aortic Heart Valve

Mitral Heart Valve

Tricuspid Heart Valve

Regional Insights

Loading chart…

The Artificial Transcatheter Heart Valve market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of transcatheter heart valve procedures, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a high prevalence of heart valve diseases, a well-established ecosystem with mature infrastructure, and a strong regulatory framework. In Europe, the key drivers are the increasing demographics of the aging population, rising healthcare expenditures, and growing awareness of transcatheter heart valve procedures. Asia Pacific is driven by rapid urbanization, increasing access to healthcare, and a large patient population. Latin America and Middle East & Africa are driven by government initiatives to improve healthcare infrastructure and a growing middle-class population with increasing healthcare demands.

The regional forecast indicates that the Artificial Transcatheter Heart Valve market will continue to grow, driven by increasing demand for minimally invasive procedures and advancements in technology. As the market evolves, it is essential to monitor the regional trends and market dynamics to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The Artificial Transcatheter Heart Valve market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Artificial Transcatheter Heart Valve competitive landscape is characterized by high competition, with companies focusing on differentiating themselves through innovative products and strategic partnerships.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Edwards Lifesciences: regional expansion

Medtronic: innovation pipeline

Abbott: premium pricing

Livanova: local manufacturing

Boston Scientific: OEM tie-ups

Cryolife: vertical integration

Key Artificial Transcatheter Heart Valve Companies12 items

Edwards Lifesciences

Medtronic

Abbott

Livanova

Boston Scientific

Cryolife

Suzhou Jiecheng Medical Technology Co.,Ltd.

Labcor Laboratórios Ltda

Braile Biomédica

MicroPort Scientific Corporation

Beijing Balance Medical Technology Co.,Ltd.

Myval

Market Ecosystem

The Artificial Transcatheter Heart Valve ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three key areas: upstream, where raw materials and components are sourced; midstream, where manufacturing and integration occur; and downstream, where channels and end users interact. Value is created and captured throughout this ecosystem as technology providers, manufacturers, and service providers collaborate to deliver innovative solutions to end users.

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and manufacturing valves

Technology providers — developing enabling technologies

System integrators / EPCs — integrating valves into larger systems

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — receiving and utilizing the artificial heart valves

In the Artificial Transcatheter Heart Valve ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and safety standards. Dependency risks arise from input constraints, such as the availability of critical components, and standards, which can vary by region. Switching costs and partnerships also play a significant role, as manufacturers and service providers must navigate complex interoperability requirements. Furthermore, the ecosystem differs by region due to diverse regulatory environments and market dynamics, underscoring the need for a nuanced value chain analysis to fully understand the intricacies of this ecosystem.

Recent Industry Insights

The Artificial Transcatheter Heart Valve industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been several strategic partnerships, such as the collaboration between Medtronic and a prominent medical research institution, aimed at advancing transcatheter valve technologies. Furthermore, the industry has seen notable mergers and acquisitions, including the acquisition of a key player by a leading medical device manufacturer, which is expected to drive innovation and expansion in the market.

Additionally, there have been several product launches and regulatory approvals, such as the FDA approval of a new transcatheter heart valve system, which is anticipated to shift consumer and enterprise trends towards more minimally invasive treatments. The industry has also seen significant funding rounds, with a major investment in a startup developing novel transcatheter valve technologies, underscoring the growing interest in this field and the potential for future growth in the Artificial Transcatheter Heart Valve industry trends.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Artificial Transcatheter Heart Valve market presents a highly attractive opportunity, driven by an increasing prevalence of heart valve disorders and a growing demand for minimally invasive treatments. The competitive intensity is moderate, with key players investing heavily in research and development to improve device efficacy and safety. The long-term Artificial Transcatheter Heart Valve market outlook is promising, with advancements in technology and materials expected to drive innovation and growth. However, the market is not without risks, including stringent regulatory requirements and potential supply chain disruptions, which may impact the demand–supply balance.

12 items

1. Executive Summary

2. Artificial Transcatheter Heart Valve Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artificial Transcatheter Heart Valve Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Artificial Transcatheter Heart Valve Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Artificial Transcatheter Heart Valve Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Artificial Transcatheter Heart Valve Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Artificial Transcatheter Heart Valve Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Artificial Transcatheter Heart Valve Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Artificial Transcatheter Heart Valve Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Artificial Transcatheter Heart Valve Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Artificial Transcatheter Heart Valve Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Artificial Transcatheter Heart Valve Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artificial Transcatheter Heart Valve Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artificial Transcatheter Heart Valve Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Artificial Transcatheter Heart Valve Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Artificial Transcatheter Heart Valve Market Competition by Key Manufacturers

9.1. Global Artificial Transcatheter Heart Valve Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Artificial Transcatheter Heart Valve: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Edwards Lifesciences

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abbott

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Livanova

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Boston Scientific

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cryolife

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Suzhou Jiecheng Medical Technology Co.,Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Labcor Laboratórios Ltda

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Braile Biomédica

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. MicroPort Scientific Corporation

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Beijing Balance Medical Technology Co.,Ltd.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Myval

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artificial Transcatheter Heart Valve Market

Figure 4: Global Artificial Transcatheter Heart Valve Market: Drivers

Figure 5: Global Artificial Transcatheter Heart Valve Market: Challenges

Figure 6: Global Artificial Transcatheter Heart Valve Market: Trends

Figure 7: Global Artificial Transcatheter Heart Valve Market: Opportunity

Figure 8: Global Artificial Transcatheter Heart Valve Market: Restraint

Figure 9: Global Artificial Transcatheter Heart Valve Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Artificial Transcatheter Heart Valve Market Value (USD Million) By Region

Figure 19: Global Artificial Transcatheter Heart Valve Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Artificial Transcatheter Heart Valve Market Value (USD Million) By Region

Figure 27: Global Artificial Transcatheter Heart Valve Market Share (%) By: Regions (2032)

Figure 28: Global Artificial Transcatheter Heart Valve Market Volume (K) By Region

Figure 29: Global Artificial Transcatheter Heart Valve Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Artificial Transcatheter Heart Valve Market Value (USD Million) By Region

Figure 37: Global Artificial Transcatheter Heart Valve Market Share (%) By: Regions (2032)

Figure 38: Global Artificial Transcatheter Heart Valve Market Volume (K) By Region

Figure 39: Global Artificial Transcatheter Heart Valve Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Artificial Transcatheter Heart Valve Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artificial Transcatheter Heart Valve Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artificial Transcatheter Heart Valve Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Artificial Transcatheter Heart Valve Market Value (USD Million) By Region

Table 14: Global Artificial Transcatheter Heart Valve Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Artificial Transcatheter Heart Valve Market Volume (K) By Region

Table 31: Global Artificial Transcatheter Heart Valve Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Artificial Transcatheter Heart Valve Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Artificial Transcatheter Heart Valve Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Artificial Transcatheter Heart Valve Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Edwards Lifesciences Basic Information And Sales Area

Table 52: Edwards Lifesciences. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Abbott Basic Information And Sales Area

Table 56: Abbott. Products Portfolio

Table 57: Livanova Basic Information And Sales Area

Table 58: Livanova. Products Portfolio

Table 59: Boston Scientific Basic Information And Sales Area

Table 60: Boston Scientific. Products Portfolio

Table 61: Cryolife Basic Information And Sales Area

Table 62: Cryolife. Products Portfolio

Table 63: Suzhou Jiecheng Medical Technology Co.,Ltd. Basic Information And Sales Area

Table 64: Suzhou Jiecheng Medical Technology Co.,Ltd.. Products Portfolio

Table 65: Labcor Laboratórios Ltda Basic Information And Sales Area

Table 66: Labcor Laboratórios Ltda. Products Portfolio

Table 67: Braile Biomédica Basic Information And Sales Area

Table 68: Braile Biomédica. Products Portfolio

Table 69: MicroPort Scientific Corporation Basic Information And Sales Area

Table 70: MicroPort Scientific Corporation. Products Portfolio

Table 71: Beijing Balance Medical Technology Co.,Ltd. Basic Information And Sales Area

Table 72: Beijing Balance Medical Technology Co.,Ltd.. Products Portfolio

Table 73: Myval Basic Information And Sales Area

Table 74: Myval. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Artificial Transcatheter Heart Valve Market Value (USD Million) By Region

Table 84: Global Artificial Transcatheter Heart Valve Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Artificial Transcatheter Heart Valve Market Volume (K) By Region

Table 101: Global Artificial Transcatheter Heart Valve Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Artificial Transcatheter Heart Valve Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	26.18 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Edwards Lifesciences; Medtronic; Abbott; Livanova; Boston Scientific; Cryolife; Suzhou Jiecheng Medical Technology Co.,Ltd.; Labcor Laboratórios Ltda; Braile Biomédica; MicroPort Scientific Corporation; Beijing Balance Medical Technology Co.,Ltd.; Myval
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options